Sharing resources to support a shared mission

The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program is funded by a consortium of private industry, public funders, and professional societies, with the shared mission of providing a strong scientific basis for the identification of dialysis and CKD practices that are most associated with improved patient survival and quality of life. Since starting in 1996, the base of funding has expanded to include grants from over 15 funders to support different facets of the collection, analysis, and dissemination of this important information.

Arbor Research Collaborative for Health recognizes supporters for their generous contributions to the DOPPS Program. Such support enables us to continue our mission to identify best practices for improving patient care, and disseminate this important information to the medical community and others in the renal industry. Arbor Research and our DOPPS collaborators gratefully acknowledge the generous support from sponsors, and their strong commitment to independent scientific research for improved patient care.

Principal Funders

  • Amgen
  • Kyowa Hakko Kirin
  • Baxter Healthcare

Additional Support

Also, our thanks to these organizations for their support of a specific DOPPS project and/or program activities in specific countries:

  • Amgen 
  • Association of German Nephrology Centres (Verband Deutsche Nierenzentren e.V.)
  • AstraZeneca 
  • European Renal Association-European Dialysis & Transplant Association (ERA-EDTA) 
  • German Society of Nephrology (DGfN) 
  • Hexal AG 
  • Janssen 
  • Japanese Society for Peritoneal Dialysis (JSPD) 
  • Keryx 
  • Proteon 
  • Relypsa 
  • Roche 
  • Società Italiana di Nefrologia (SIN) 
  • Spanish Society of Nephrology 
  • Vifor Fresenius Medical Care Renal Pharma

Public funding and support is provided for specific DOPPS projects, ancillary studies, or affiliated research projects by: 
  • Australia: National Health & Medical Research Council (NHMRC) 
  • Canada: Canadian Institutes of Health Research (CIHR) and Ontario Renal Network 
  • France: Agence Nationale de la Recherche 
  • Thailand: Thailand Research Foundation (TRF), Chulalongkorn University Matching Fund, King Chulalongkorn Memorial Hospital Matching Fund, and the National Research Council of Thailand (NRCT) 
  • United Kingdom: National Institute for Health Research (NIHR) via the Comprehensive Clinical Research Network (CCRN) 
  • United States: National Institutes of Health (NIH) and Patient-Centered Outcomes Research Institute (PCORI)